Head to head
T. Rowe Price vs Blackrock
Side-by-side on the measures that matter, with a plain-English read. Full detail: TROW · BLK
TROW
T. Rowe Price
100.99-3.74%
1-year price shape — +9% over the period
Quant Rating C · 54/100
vs
BLK
Blackrock
1,101.72-3.00%
1-year price shape — +13% over the period
Quant Rating C · 54/100
1-year performance, rebased to 100
Blackrock edges it on the scoreable measures. Blackrock has done best over the past year (+13%); Blackrock earns the most per share.
| TROW | BLK | |
|---|---|---|
| Snapshot | ||
| Sector | Asset Management | Asset Management |
| Last price | 100.99 | 1,101.72 |
| Change today | -3.74% | -3.00% |
| 1-year return | +9.2% | +12.8% |
| Market cap | $21.54B | $170.13B |
| 52-week range | 83.17 – 120.50 | 907.59 – 1,242.12 |
| Valuation | ||
| P/E (TTM) | 10.22 | 25.08 |
| P/E percentile, own 5-yr range | 25th | 92nd |
| P/B | 1.89 | 2.93 |
| Dividend yield | 5.12% | 2.03% |
| Profitability & growth | ||
| EPS (TTM) | 9.24 | 35.31 |
| Net profit (TTM) | $1.97B | $5.45B |
| Revenue (TTM) | $7.70B | $28.54B |
| Provider revenue period date | 2026-09-29 | 2026-09-29 |
| Revenue growth (YoY) | +5.9% | +19.1% |
| Gross margin | 52.2% | 48.3% |
| Operating margin | 35.1% | 34.5% |
| Net margin | 27.7% | 24.2% |
| Free cash flow (TTM) | $1.60B | $4.78B |
| Provider cash-flow period date | 2026-09-29 | 2026-09-29 |
| Ownership & sentiment | ||
| Institutional ownership | 90.4% | 85.3% |
| Insider activity (12mo) | 47 buy / 3 sell | 34 buy / 15 sell |
| Short interest (% of float) | 12.8% | 1.4% |
| Analyst consensus | 75% hold / 25% sell (8) | 100% buy (14) |
| Analyst price target | $107 (+6%) | $1,373 (+25%) |
| StockVane view | ||
| StockVane Quant Rating | C (54) | C (54) |
| Company | ||
| Employees | 7,773 | 24,900 |
| Founded | 1937 | 1988 |
▲ marks the more favourable stock(s) on measures with a clear direction (lower P/E, higher yield, higher Quant Rating, better 1-year return). Analyst consensus counts each covering institution once, at its most recent rating. Not a recommendation. Quant Rating method: Data & Methodology.